Roxane Laboratories   Report issue

Contributed to NME For profit Phase 1 Phase 3 Phase 4
Founded: Columbus OH United States (1885)
Status: Acquired by Boehringer Ingelheim (1978)

Organization Overview

First Clinical Trial
1999
NCT00000737
First Marketed Drug
1971
prednisone (meticorten)
First NDA Approval
1993
levomethadyl acetate (orlaam)
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ROXANE